ILUX DRY EYE
Over 85% of chronic dry eye disease is caused by Meibomian Gland Dysfunction (MGD). Meibomian glands are found in your upper and lower eyelids and secrete meibum, or oils, that create a protective film over your tears. Patients with MGD do not properly produce enough meibum, breaking down the protective tear film and allowing for tears to evaporate. As the affected glands become increasingly inflamed, the normally oily secretions become thick like butter, restricting gland secretion. In many patients, glands affected by MGD can atrophy, leading to permanent gland death. It is important to identify and treat this disease early.
The newest dry eye treatment technology, iLux, is a handheld device that uses light source heating and compression intended to help your Meibomian glands express oils to protect your tears.
iLux is the only handheld FDA approved treatment for MGD uniquely designed to customize treatments for each patient. Patients describe the treatment as a “warm eye massage” that lasts about 8 minutes, and typically eases symptoms for 6-8 months. In order to assess if iLux is right for you, your eye care professional will perform diagnostic tests to evaluate your gland health.